Javascript must be enabled to continue!
Clinical Characteristics and Outcomes of Patients with COVID-19 Infection and Acute Ischemic Stroke at Eka Kotebe General Hospital in Addis Ababa, Ethiopia
View through CrossRef
BACKGROUND: Acute ischemic stroke has been reported to occur in a significantly higher number of COVID-19 patients as compared to healthy controls with variable proposed pathophysiologic mechanisms. To our knowledge, sufficient data regarding this subject is lacking in Ethiopia and the African continent at large. In this case series, we report the clinical characteristics and management of 5 cases with COVID-19 infection and acute ischemic stroke to shed light on the diagnostic and therapeutic challenges in resource-limited setups.METHODS: This is a case series including data collected from the medical records of 5 participants with confirmed RT-PCR positive COVID-19 infection and radiologically confirmed acute ischemic stroke, admitted at Eka Kotebe General Hospital Intensive Care Unit (ICU) in Addis Ababa, Ethiopia from June 10, 2020, to November 04, 2020.RESULTS: Cryptogenic stroke was documented in 4/5 participants included in this series with the most common vascular risk factors identified for stroke being hypertension and diabetes mellitus. The median time from onset of COVID-19 symptoms to the identification of stroke was 07 days. Two fifth of the participants in this series died during their ICU admission with the immediate cause of deaths reported to be related to the severe COVID-19 infection but not stroke.CONCLUSION: Cryptogenic stroke was documented in 4/5 patients in this series despite the presence of vascular risk factors for other stroke subtypes. The overall prevalence, subtypes, and outcomes of stroke in COVID-19 patients in Ethiopia and the African continent as a whole needs additional research to elucidate the local burden of the disease and define the predominant pathophysiologic mechanisms for stroke in COVID-19 in the region.
Title: Clinical Characteristics and Outcomes of Patients with COVID-19 Infection and Acute Ischemic Stroke at Eka Kotebe General Hospital in Addis Ababa, Ethiopia
Description:
BACKGROUND: Acute ischemic stroke has been reported to occur in a significantly higher number of COVID-19 patients as compared to healthy controls with variable proposed pathophysiologic mechanisms.
To our knowledge, sufficient data regarding this subject is lacking in Ethiopia and the African continent at large.
In this case series, we report the clinical characteristics and management of 5 cases with COVID-19 infection and acute ischemic stroke to shed light on the diagnostic and therapeutic challenges in resource-limited setups.
METHODS: This is a case series including data collected from the medical records of 5 participants with confirmed RT-PCR positive COVID-19 infection and radiologically confirmed acute ischemic stroke, admitted at Eka Kotebe General Hospital Intensive Care Unit (ICU) in Addis Ababa, Ethiopia from June 10, 2020, to November 04, 2020.
RESULTS: Cryptogenic stroke was documented in 4/5 participants included in this series with the most common vascular risk factors identified for stroke being hypertension and diabetes mellitus.
The median time from onset of COVID-19 symptoms to the identification of stroke was 07 days.
Two fifth of the participants in this series died during their ICU admission with the immediate cause of deaths reported to be related to the severe COVID-19 infection but not stroke.
CONCLUSION: Cryptogenic stroke was documented in 4/5 patients in this series despite the presence of vascular risk factors for other stroke subtypes.
The overall prevalence, subtypes, and outcomes of stroke in COVID-19 patients in Ethiopia and the African continent as a whole needs additional research to elucidate the local burden of the disease and define the predominant pathophysiologic mechanisms for stroke in COVID-19 in the region.
Related Results
Iranian stroke model-how to involve health policymakers
Iranian stroke model-how to involve health policymakers
Stroke in Iran, with more than 83 million population, is a leading cause of disability and mortality in adults. Stroke has higher incidence in Iran comparing the global situation a...
Comparative Characterization of Candidate Molecular Markers in Ischemic and Hemorrhagic Stroke
Comparative Characterization of Candidate Molecular Markers in Ischemic and Hemorrhagic Stroke
According to epidemiological studies, the leading cause of morbidity, disability and mortality are cerebrovascular diseases, in particular ischemic and hemorrhagic strokes. In rece...
Outcome of vaccinated COVID-19 patients at Eka Kotebe General Hospital, national COVID-19 treatment center Addis Ababa, Ethiopia.
Outcome of vaccinated COVID-19 patients at Eka Kotebe General Hospital, national COVID-19 treatment center Addis Ababa, Ethiopia.
Abstract
Introduction: The majority of wealthy countries are distributing the COVID-19 vaccine to their citizens, and the World Health Organization has registered more than...
Prevalence of Diabetes Mellitus in Acute Ischemic Stroke Patients at Tertiary Care Hospital
Prevalence of Diabetes Mellitus in Acute Ischemic Stroke Patients at Tertiary Care Hospital
Back ground: The third largest cause of death around the globe is stroke. In the United States the largest cause of disability is also stroke. For stroke and coronary heart diseas...
Unveiling the Burden of Cardiovascular Disorders in Pediatric Stroke—Insights from Pakistan
Unveiling the Burden of Cardiovascular Disorders in Pediatric Stroke—Insights from Pakistan
Pediatric stroke, though relatively uncommon, poses significant clinical challenges due to its high rates of morbidity and mortality [1]. Its incidence varies with age, remaining l...
Clinical Features, Risk Factors and Hospital Mortality of Acute Stroke Patients
Clinical Features, Risk Factors and Hospital Mortality of Acute Stroke Patients
Background: Stroke is a leading cause of mortality and disability worldwide. To prevent complications and permanent defects, early diagnosis, distinguishing the type and risk facto...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Abstract TP294: The Impact of Chronic Kidney Disease Severity on Incident Acute Ischemic Stroke
Abstract TP294: The Impact of Chronic Kidney Disease Severity on Incident Acute Ischemic Stroke
Introduction:
Chronic kidney disease (CKD) and ischemic stroke are both associated with significant global disease burdens and share common risk factors. Understanding ...

